Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Isis Pharma receives US$ 10 mn from OncoGenex' license of OGX-O11 to Teva
Isis Pharma receives US$ 10 mn from OncoGenex' license of OGX-O11 to Teva
Isis Pharma receives US$ 10 mn from OncoGenex' license of OGX-O11 to Teva
Submitted by
admin
on December 28, 2009 - 4:51am
Source:
Pharmabiz
News Tags:
Isis Pharmaceuticals
Teva Pharmaceuticals
licensing
antisense
OncoGenex
Headline:
Isis Pharma receives US$ 10 mn from OncoGenex' license of OGX-O11 to Teva
Do Not Allow Advertisers to Use My Personal information
